Loading organizations...
Loading organizations...
Biotech company developing immune-modulating therapies for diseases.
Asylia Therapeutics has raised $14.5M across 1 funding round.
Asylia Therapeutics has raised $14.5M in total across 1 funding round.
Asylia Therapeutics has raised $14.5M in total across 1 funding round.
Asylia Therapeutics's investors include Michael D. Wyzga.
Asylia Therapeutics has raised $14.5M across 1 funding round. Most recently, it raised $14.5M Series A in May 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 25, 2021 | $14.5M Series A | Michael D. Wyzga |